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Abstract
Background: Mathematical modeling of perfusion cardiovascular magnetic resonance (CMR) data allows absolute
quantification of myocardial blood flow and can potentially improve the diagnosis and prognostication of
obstructive coronary artery disease (CAD), against the current clinical standard of visual assessments. This study
compares the diagnostic performance of distributed parameter modeling (DP) against the standard Fermi model,
for the detection of obstructive CAD, in per vessel against per patient analysis.
Methods: A pilot cohort of 28 subjects (24 included in the final analysis) with known or suspected CAD underwent
adenosine stress-rest perfusion CMR at 3T. Data were analysed using Fermi and DP modeling against invasive
coronary angiography and fractional flow reserve, acquired in all subjects. Obstructive CAD was defined as luminal
stenosis of ≥70 % alone, or luminal stenosis ≥50 % and fractional flow reserve ≤0.80.
Results: On ROC analysis, DP modeling outperformed the standard Fermi model, in per vessel and per patient
analysis. In per patient analysis, DP modeling-derived myocardial blood flow at stress demonstrated the highest
sensitivity and specificity (0.96, 0.92) in detecting obstructive CAD, against Fermi modeling (0.78, 0.88) and visual
assessments (0.79, 0.88), respectively.
Conclusions: DP modeling demonstrated consistently increased diagnostic performance against Fermi modeling
and showed that it may have merit for stratifying patients with at least one vessel with obstructive CAD.
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Background
Perfusion cardiovascular magnetic resonance (CMR) is a
technique that allows the non-invasive assessment of cor-
onary artery disease (CAD) [1, 2]. Clinically, the current
standard method of assessment of perfusion CMR is based
either on visual estimates of the images, or on a semi-
quantitative assessment of perfusion index [3, 4]. Visual
assessments of areas of abnormal perfusion rely on the
presence of myocardial areas with normal perfusion for
direct comparison. Visual estimates are particularly diffi-
cult in multi-vessel disease where there may be minimal
areas of normal perfusion to compare against, or in cases
of severe left ventricular impairment [5] in which slow
bolus dispersion leads to low contrast enhancement glo-
bally within the myocardium. Mathematical modeling of
perfusion imaging data allows absolute quantification of
myocardial blood flow (MBF) and it may be particularly
useful in cases in which visual assessment is compro-
mised. By quantifying perfusion, it also has the potential
to minimize interobserver variability and to improve the
diagnosis and prognostication of CAD [5, 6].
Fermi deconvolution modeling is an empirical-
mathematical model used to estimate MBF from perfusion
CMR data during first-pass of gadolinium-based extracel-
lular contrast agents [7]. Distributed parameter (DP) de-
convolution modeling is based upon physiological
principles of tracer kinetics analysis and it can provide
MBF quantification and additional information about cor-
onary vascularity and permeability [8]. This includes esti-
mates of intravascular space, extravascular-extracellular
space, permeability surface area product, extraction frac-
tion and volume of distribution.
Fermi modeling is currently the most popular ap-
proach for quantitative analysis of perfusion CMR data
[5]. The diagnostic performance of Fermi modeling in
detecting obstructive CAD has been assessed, with vari-
able conclusions whether it provides additive clinical
information to visual assessment [9] or not [5, 10]. In
contrast to Fermi modeling, the diagnostic performance
of DP modeling has not at this point been assessed
against invasive clinical standard methods. In addition,
there is still a disagreement whether Fermi modeling
can provide haemodynamic thresholds either in per
vessel [5, 10] or in per patient [11] basis, for robust pa-
tient stratification in the presence of obstructive CAD.
A model comparison in per vessel against per patient
analysis has not been fully assessed yet in a single CMR
study.
The objective of this study was two-fold. Firstly, to in-
vestigate whether either Fermi or DP modeling may be
more accurate in detecting reduced MBF in obstructive
CAD, when compared against the current invasive clin-
ical standard assessment of invasive coronary angiog-
raphy and fractional flow reserve in a pilot population.
The second objective of this study was to assess the
diagnostic performance of both models in per vessel
against per patient based analysis in this pilot
population.
Methods
Study population and design
28 patients with history of stable angina and with
known or suspected CAD were recruited for perfusion
CMR. Exclusion criteria for all subjects included history
of severely compromised renal function (Glomerular
filtration rate ≤ 30 mL/min), pregnancy and contraindi-
cations to CMR. The study was performed with the ap-
proval of the institutional research ethics committee, in
accordance with the Declaration of Helsinki and with
the written informed consent of all subjects. All sub-
jects were instructed to abstain from caffeine for 12 h
before CMR. All patients underwent invasive coronary
angiography and fractional flow reserve.
Cardiac magnetic resonance imaging
Perfusion CMR was acquired using a 3T Verio imaging
system (Siemens, Healthcare Gmbh, Erlangen, Germany)
using electrocardiogram-gating, as previously described
[12]. Standard cardiac imaging planes and a short axis
stack of left ventricular cine data were acquired using
routine steady state free precession (TrueFISP) acquisi-
tions. T1 MOLLI maps were acquired using the Siemens
Works in Progress Package #448, Quantitative Cardiac
Parameter Mapping [13]. Stress imaging was performed
by intravenously administering 140 μg/kg/min of adeno-
sine (Adenoscan, Sanofi Aventis) for 4 min and confirm-
ation of patient symptoms. Fifty dynamic perfusion
images were obtained at diastole across three short-axis
view slices, covering 16 of the standard myocardial seg-
ments [14]. A turbo-fast low angle shot saturation recov-
ery prepared single-shot gradient echo pulse sequence
was used with imaging parameters: repetition time/ echo
time 2.20 ms/1.07 ms, flip angle 12o, slice thickness
8 mm, preparation pulse delay to central line of k-space
100 ms, matrix size 192 × 108 and FoV 330 mm x
440 mm. With the application of GRAPPA (accelerator
factor of 3) and partial Fourier acquisition of 0.75, each
dynamic frame consisted of 48-phase encoding lines.
An intravenous bolus of 0.05 mmol/kg of a
gadolinium-based contrast agent (Gadovist, Bayer
Healthcare) was injected at 4 mL/s using an MR-
compatible pump injector (Spectris Solaris, Medrad,
Bayer). To allow clearance of residual contrast agent,
rest perfusion imaging was performed 15 min after the
adenosine-stress scan by repeating the same acquisition
protocol in all subjects.
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Invasive coronary angiography and fractional flow
reserve
All patients underwent invasive coronary angiography
and fractional flow reserve at the Royal Infirmary of Ed-
inburgh. Fractional flow reserve was assessed for major
epicardial vessels and defined as the ratio between distal
coronary pressure and aortic pressure measured simul-
taneously at maximal adenosine-induced (intravenous
140 μg/kg/min) hyperaemia [15, 16]. Haemodynamically
significant (obstructive) CAD was defined as luminal
stenosis ≥70 % on invasive coronary angiography, or
fractional flow reserve <0.80 and luminal stenosis ≥50 %.
Outcomes from the three main coronary vessels were
classified into 2 groups: Group 1, (no, minor or non)-ob-
structive CAD with luminal stenosis <50 % or with lu-
minal stenosis ≥50 % and fractional flow reserve > 0.80;
Group 2, obstructive CAD with luminal stenosis of
≥70 % alone, or luminal stenosis ≥50 % and fractional
flow reserve ≤0.80 [15, 16].
Visual analysis
Perfusion CMR images were analyzed by 2 experienced
observers blinded to all other data. The perfusion CMR
scans were reported for the three main epicardial vessel
territories and classified as positive for obstructive CAD
in the presence of a stress-induced perfusion defect
which was transmural and/or involved ≥ 1 myocardial
segment, corresponding to the maximum sensitivity and
specificity [10]. In the event of disagreement, the images
were reviewed together and a consensus was reached.
Quantitative CMR analysis
Endocardial and epicardial MR contours were outlined
using dedicated cardiac image analysis software (QMass,
Medis, The Netherlands) to generate a standardised 16-
segment American Heart Association (AHA) model of
the heart (reference marker for myocardial segmentation
was placed in the anteroseptal conjunction of the left
and right ventricle) [14]. Quantification of MBF was per-
formed using customised in-house software developed in
Matlab (MathWorks Inc., Natick, MA), as previously de-
scribed [12]. Myocardial and arterial input function sig-
nal intensity-time curves were converted to gadolinium
concentration-time curves using the method of Larsson
et al (see details in Additional file 1) [17]. Model-
dependent deconvolution analysis was implemented to
measure MBF using Fermi and 1-barrier 2-region DP
functions as previously described (see details and func-
tions in Additional file 2) [12]. To account for the delay
time between the onset of contrast enhancement in the
arterial input function and the myocardium, both
models were fitted to the data multiple times, from zero
to six times the temporal resolution at dynamic perfu-
sion acquisition. The delay time reaching the optimal x2
fit to the data was used in the analysis [11, 12]. In DP
modeling, additional microvascular characteristics were
also calculated (Additional file 3). Myocardial perfusion
reserve (MPR) was calculated by dividing the hyperemic
MBF by the resting flow. The mean myocardial perfu-
sion reserve of the two lowest scoring myocardial seg-
ments (MPR2) was also calculated for each vessel
territory and its accuracy in detecting obstructive CAD
was examined [5, 10]. Both models were applied to each
of the 16 AHA segments. MBF, MPR and MPR2 were
then averaged per epicardial vessel territory (vessel terri-
tories corresponded to the three main coronary vessels,
also defined according to the 16 segment AHA model
[14]). Mean values for MBF at stress, MPR and MPR2
were classified accordingly for per vessel and per patient
based analysis (see classification in the results section re-
ferring to visual MR analysis).
Statistical analysis
Dedicated software were used for statistical analysis (R
Foundation for statistical computing, Vienna, Austria,
Analyse-it, Analyse-it Software, Leeds, England).
Receiver-operating characteristic (ROC) analysis was
used to determine threshold values for absolute MBF at
stress, MPR and MPR2 with the greatest sensitivity and
specificity to detect obstructive CAD (Group 2 versus
Group 1). The maximal Youden Index was used to de-
termine the optimal threshold values [5, 10]. The area
under the curve (AUC) was calculated using trapezoidal
numerical integration and a Delong et al nonparametric
comparison was used to compare the diagnostic per-
formance of quantitative methods [18]. Bland Altman
plots were used to investigate systematic bias between
Fermi and DP modeling values for MBF, MPR and
MPR2.
An interobserver reliability analysis was performed for
visual estimates using Cohen kappa statistic. Statistical dif-
ferences in MBF values and in myocardial perfusion ratios
between patient Groups (Group 2 against Group 1), were
investigated by implementing a two sample t-test. Statis-
tical significance was defined as two-sided P value < 0.05.
Results
Patients
The baseline demographics of the patient cohort are
presented in Table 1. In the final analysis, data from 24
patients were used. Quantitative perfusion analysis was
performed in 72 vessel territories in total. 3 patients did
not complete the imaging session due to claustrophobia.
1 patient was excluded from the analysis due to electro-
cardiographic failures which caused considerable
through plane motion.
All patients underwent invasive coronary angiography
and fractional flow reserve assessment. 16 patients (67 %)
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had at least 1 vessel territory classified with obstructive
CAD (Group 2). 10 patients had 1-vessel disease, 2 had 2-
vessel disease and 4 had 3-vessel disease.
Visual CMR analysis
The interobserver variability was kappa = 0.81 (95 % CI:
0.73 to 0.89). In per vessel analysis, vessel classification
occurred using the cut off criteria described in the
methods section for invasive assessments. In per patient
analysis, patients with all vessel territories identified
with (no, minor or non)- obstructive CAD were classi-
fied in Group 1, whilst patients with at least one vessel
detected with obstructive CAD, were classified in
Group 2. Based on these criteria (applied for both vis-
ual and quantitative CMR analysis), diagnostic perform-
ance (i.e. sensitivity, specificity, positive predictive value
and negative predictive value) in per vessel and per pa-
tient visual MR analysis against invasive methods, are
presented in Table 2. Examples of MR perfusion images
are presented in Fig. 1.
Quantitative CMR analysis
Initially, quantitative MBF analysis was performed on a
per vessel basis. Examples of arterial input function and
model fitting for both models are shown in Fig. 2. Mean
values for all Fermi- and DP modeling-derived haemo-
dynamic parameters (i.e. absolute MBF at stress, MPR
and MPR2), for both Groups 1 and 2, are presented in
Table 3.
Table 4 demonstrates results for each model. Signifi-
cant differences in haemodynamic parameter values be-
tween Groups 1 and 2 were considerably higher for DP
modeling, compared to Fermi modeling (Table 4). No
differences were observed for blood flow values at rest
between Groups 1 and 2, for both models. Significant
differences were observed in all DP modeling-derived
microvascular characteristics, between Groups 1 and 2
(all P ≤0.01). Mean values for microvascular characteris-
tics are also presented (Additional file 4).
Systematic bias between Fermi- and DP modeling-
derived values was investigated using Bland Altman
plots (Additional file 5). The average bias was calculated
as the Fermi modeling-derived estimates minus the DP
modeling-derived estimates across all three haemo-
dynamic parameters. For MBF at stress, MPR and
MPR2, the average bias (95 % CI) was 0.55 (-0.51, 1.62),
0.38 (-0.54, 1.31), 0.25 (0.51, 1.00), respectively.
ROC analysis graphs are illustrated in Fig. 3. Haemo-
dynamic thresholds defined on ROC analysis (Table 4)
as compared to mean values for MBF at stress are illus-
trated in Fig. 4a. The AUC for MPR2 was significantly
higher compared to both MBF at stress and MPR for
Fermi modeling (Table 4). There were no significant dif-
ferences between ROC curves across all three haemo-
dynamic parameters for DP modeling (Table 4).
Table 5 shows comparisons on ROC analysis between
Fermi and DP modeling across all three haemodynamic
parameters. Significant differences were observed in
AUC between Fermi and DP modeling, except for the
case of MPR2 (Table 5). The diagnostic performance was
consistently higher for DP modeling, compared to Fermi
modeling (Table 6).
Following per vessel analysis, quantitative MBF ana-
lysis was investigated on a per patient basis. Mean
values for all three Fermi- and DP modeling-derived
Table 1 Baseline demographics
Parameter Data (n = 24)
Age (yrs) 63 ± 7
Male 20 (83)
BMI 29 ± 5
Hypertension 13 (54)
Hct 0.43 ± 0.02
Diabetes
Type 1 0 (0)
Type 2 3 (13)
Angina 23 (96)
NSTEMI 4 (17)
STEMI 3 (13)
PVD 0 (0)
CVD 2 (8)
Smoking
Current 6 (25)
Previous 15 (63)
PCI 4 (17)
Medication
Statin 21 (88)
Beta-blocker 20 (83)
Angiographic data (per vessel)
Group 1 46 (64)
Group 2 26 (36)
Parentheses show (%). BMI Body mass index, Hct haematocrit, NSTEMI non-ST
segment elevation myocardial infarction, STEMI ST segment elevation myocar-
dial infarction, PVD peripheral vascular disease, CVD cardiovascular disease, PCI
percutaneous coronary intervention
Table 2 Diagnostic performance of visual CMR estimates
Visual estimates from MR Per vessel Per patient
Sensitivity 0.73 (0.50, 0.88) 0.79 (0.49, 0.94)
Specificity 0.80 (0.64, 0.89) 0.88 (0.47, 0.99)
PPV 0.64 (0.43, 0.81) 0.92 (0.60, 0.99)
NPV 0.85 (0.70, 0.94) 0.70 (0.35, 0.92)
Sensitivity, specificity, PPV, NPV is shown in per vessel and per patient analysis.
Parentheses show (95 % confidence intervals). MR magnetic resonance, PPV
positive predictive value, NPV negative predictive value
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haemodynamic parameters for Groups 1 and 2 are
presented in Table 3.
Significant differences in haemodynamic parameter
values between Groups 1 and 2 increased further for
both models, with DP modeling demonstrating consist-
ently greater differences, compared to Fermi modeling
(Table 4).
Haemodynamic thresholds on ROC analysis and mean
values for MBF at stress in per patient analysis are dem-
onstrated in Fig. 4b. The AUC were generally increased
in per patient analysis, in comparison with per vessel
analysis (Table 4). No significant differences were ob-
served in ROC curves between haemodynamic parame-
ters for either model, in per patient analysis (Table 4).
The AUC were significantly superior for DP modeling,
compared to Fermi modeling ( Fig. 5, Table 5). The diag-
nostic performance of both models was increased in per
patient analysis compared against per vessel analysis,
with DP modeling outperforming Fermi modeling across
all three haemodynamic parameters (Table 6).
Discussion
The main findings of this study demonstrated that DP
modeling outperformed the standard Fermi modeling in
the setting of obstructive CAD detection, in both per
vessel and per patient analysis. When compared with
visual and quantitative CMR analysis, DP modeling-
derived MBF at stress in per patient analysis, showed the
highest diagnostic performance for the detection of ob-
structive CAD in our pilot population.
Visual versus quantitative CMR analysis
The interobserver variability for visual analysis was simi-
lar to a previously published value [10] and higher com-
pared to another study [9]. In per vessel based analysis,
visual CMR estimates gave higher specificity compared
d)
f)
a)
b)
c)
e)
Fig. 1 Perfusion CMR images from a patient with minor CAD (a, b, c) and a patient with (1-vessel) right coronary artery disease (d, e, f). White
arrows show perfusion defect in the inferior and inferoseptal myocardial regions. Basal (a, d), mid-ventricular (b, e) and apical slices (c, f)
are shown
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to quantitative CMR estimates (Tables 2 versus 6). How-
ever, quantitative CMR analysis showed superior sensi-
tivity using both Fermi and DP modeling-derived MBF
at stress, compared to visual CMR assessments.
In per patient based analysis, DP modeling demon-
strated superior diagnostic performance in detecting ob-
structive CAD, compared to visual CMR estimates
(Tables 2 versus 6).
Distributed parameter versus Fermi analysis
This is the first study assessing the diagnostic perform-
ance of 1-barrier 2-region DP modeling in 24 patients
with known or suspected CAD, against invasive
methods. Studies assessing the diagnostic performance
of fully quantitative perfusion CMR methods in patients
have mainly focused on the use of Fermi modeling [5, 9,
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Fig. 2 Arterial input functions and model fits on myocardial tissue curves from a patient with minor (a, b, c) and a patient with 1-vessel (d, e, f)
CAD. a, d, b, e, c, f show arterial input functions, Fermi modeling and distributed parameter modeling fits, respectively. Gd: gadolinium
Table 3 Mean (SD) values for MBF at stress, MPR and MPR2, for
Groups 1 and 2
Haemodynamic
parameter-Model
Per vessel Per patient
Group 1 Group 2 Group 1 Group 2
MBF Fermi (mL/min/mL) 2.49 (0.96) 1.96 (0.66) 3.07 (0.71) 1.97 (0.75)
MBF DP (mL/min/mL) 2.01 (0.71) 1.36 (0.39) 2.53 (0.37) 1.41 (0.46)
MPR Fermi 2.09 (0.85) 1.55 (0.59) 2.61 (0.76) 1.61 (0.59)
MPR DP 1.78 (0.71) 1.12 (0.38) 2.26 (0.61) 1.21 (0.39)
MPR2 Fermi 1.79 (0.81) 1.08 (0.45) 2.24 (0.77) 1.19 (0.49)
MPR2 DP 1.53 (0.65) 0.86 (0.31) 1.97 (0.56) 0.95 (0.32)
Mean values in per vessel and per patient based analysis. MBF myocardial
blood flow, MPR myocardial perfusion reserve, MPR2 myocardial perfusion
reserve of the two lowest scoring segments, DP distributed
parameter modeling
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10, 19], or on a model-independent approach [20], for
detecting obstructive CAD. A recent perfusion CMR
study has assessed four different model applications
(Fermi model, uptake model, one-compartmental model,
model-independent approach) at 1.5T, in which it was
shown that the diagnostic performance of quantitative
MR analysis did not significantly differ between model-
ing methods, for obstructive CAD detection [11]. In our
data analysis, the diagnostic power of Fermi modeling
was in agreement with previously published studies [5,
9–11, 19]. However, DP modeling showed significantly
higher diagnostic performance compared to Fermi mod-
eling, which was consistent throughout both per vessel
and per patient based analysis.
To date, no other perfusion CMR study has accurately
identified perfusion abnormalities in the presence of sig-
nificant CAD using only MBF value at stress as a meas-
ure (estimated per epicardial vessel territory). Perfusion
CMR studies have instead defined the use of the lowest
scoring segments for detecting obstructive CAD. This
approach was applied either by using MPR as measure
[5, 10, 19], or MBF at stress as measure [20], or both
[11]. Patel et al. used Fermi modeling-derived MPR, to
assess quantitative MR analysis in patients with
obstructive CAD [9]. In our data, no differences were
observed between all three haemodynamic parameters
for either model, other than the case of the Fermi mod-
eling derived-MPR2, which showed improvement against
MBF at stress and MPR, in per vessel analysis. This
agrees with previous studies demonstrating no difference
between MBF at stress and MPR when the measure of
the lowest scoring segments was examined [11, 20].
The optimal thresholds in per vessel (1.75 mL/min/mL)
and in per patient (2.00 mL/min/mL) analysis for DP
modeling-derived MBF at stress (Table 4), were in agree-
ment with a previous positron emission tomography (PET)
myocardial perfusion study (1.85 mL/min/mL) which
aimed to localise perfusion defects to significantly stenotic
coronary arteries in per vessel and per patient basis (≥70 %
on invasive angiograms) [21]. It is important to note that
PET is currently considered the reference standard for ab-
solute non-invasive quantification of MBF [1, 5, 21].
The Fermi model demonstrated higher haemodynamic
thresholds in both per vessel (2.49 mL/min/mL) and per
patient (2.60 mL/min/mL) based analysis, compared to
DP modeling (Table 4). Threshold values for Fermi mod-
eling were in agreement with a previously published
value (2.30 mL/min/mL) [22]. However, thresholds for
Table 4 Results from t-test and ROC analysis in per vessel and per patient based analysis
Statistical analysis/
Model
Per vessel Per patient
Fermi DP Fermi DP
P values from t-test comparisons
MBF (G1 vs G2) 0.02* <0.0001 † <0.00001* <0.00001 †
MPR (G1 vs G2) <0.01* <0.0001 † <0.00001* <0.00001 †
MPR2 (G1 vs G2) <0.00001* <0.00001 † <0.00001* <0.00001 †
AUCs from ROC analysis
MBF 0.68 (0.55, 0.80) 0.76 (0.65, 0.87) 0.86 (0.77, 0.94) 0.97 (0.92, 1.00)
MPR 0.69 (0.56, 0.81) 0.79 (0.68, 0.89) 0.85 (0.75, 0.94) 0.94 (0.87, 1.00)
MPR2 0.77 (0.66, 0.88) 0.82 (0.72, 0.92) 0.88 (0.80, 0.96) 0.96 (0.91, 1.00)
Thresholds on ROC analysis
MBF (mL/min/mL) 2.49 1.75 2.60 2.00
MPR 1.76 1.45 1.88 1.59
MPR2 1.36 1.07 1.49 1.47
P values from comparisons of ROC curves between haemodynamic parameters
MBF vs MPR 0.81 0.54 0.80 0.35
MBF vs MPR2 0.04* 0.19 0.45 0.68
MPR vs MPR2 0.0022* 0.20 0.17 0.33
Difference in AUC of ROC curves between haemodynamic parameters
MBF vs MPR -0.01 (-0.10, 0.08) -0.03 (-0.11, 0.05) 0.01 (-0.06, 0.08) 0.03 (-0.03, 0.09)
MBF vs MPR2 -0.09 (-0.18, 0.01) -0.06 (-0.14, 0.02) -0.03 (-0.10, 0.04) 0.01 (-0.04, 0.06)
MPR vs MPR2 -0.08 (-0.16, 0.01) -0.03 (-0.09, 0.02) -0.04 (-0.09, 0.01) -0.02 (-0.06, 0.02)
Statistically significant differences are indicated with * and † († show at least two orders of magnitude smaller P values compared to *, both in per vessel and per
patient analysis). Parentheses show (95 % confidence intervals). MBF myocardial blood flow, MPR myocardial perfusion reserve, MPR2 myocardial perfusion reserve
of the two lowest scoring segments, AUC area under the curve, DP distributed parameter modeling, G1 Group 1, G2 Group 2
Papanastasiou et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:57 Page 7 of 12
Fermi modeling were in a slightly higher range com-
pared to other PET perfusion studies (1.86, 2.50 and
2.45 mL/min/mL) [23–25] respectively, which aimed to
identify perfusion abnormalities against lower angio-
graphic thresholds (≥50 % on invasive angiograms). In
our analysis, higher perfusion estimates were observed
for Fermi modeling compared to DP modeling, across
all three haemodynamic parameters (Table 3, Bland Alt-
man plot analysis). In the same context, other perfusion
studies demonstrated that the Fermi model estimates
MBF values that were systematically increased compared
to DP modeling [12, 26], to two-compartmental model-
ing, model-independent and Patlak model analysis [27],
as well as against PET imaging data analysed with the
Patlak model [5]. It is known that arterial input function
saturation effects that may be present in single bolus
data can result in significant overestimation of MBF in
Fermi modeling [28]. Our group has previously demon-
strated that the DP model can be less dependent on ar-
terial input function saturation effects, compared to the
Fermi model [12]. Any MBF overestimations using
Fermi modeling may have become pronounced in some
of our subjects due to saturation effects in our single
bolus data. This may explain its lower sensitivity in de-
tecting hypoperfusion in obstructive CAD (susceptible
to false negatives), compared to DP modeling.
Per vessel versus per patient quantitative analysis
The significant differences between (no, minor or non)-
obstructive and obstructive CAD (Table 4 and 5), the
AUC (Table 4, Figs. 3 and 5) and the diagnostic perform-
ance (Table 6) of both models were considerably superior
in per patient analysis, compared to per vessel analysis.
DP modeling-derived MBF at stress in per patient analysis
demonstrated the highest diagnostic performance in de-
tecting impaired haemodynamics in obstructive CAD
(Table 6) and compares favourably against previous find-
ings [9, 11]. These outcomes indicate that it may have
merit for the stratification of patients with at least one
vessel with obstructive CAD.
The specificities and positive predictive values in per ves-
sel based analysis were in agreement with those reported by
a previous study [19], but in a lower range compared to
other investigations [5, 10]. Quantitative CMR analysis
identified hypoperfusion in vessels with (no, minor or non)-
obstructive CAD, which increased the false positives in per
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Fig. 3 ROC curves presenting diagnostic performance for both models in per vessel analysis with (a), (b) and (c) showing measures of myocardial
blood flow at stress, myocardial perfusion reserve and myocardial perfusion reserve of the two lowest scoring segments, respectively
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vessel analysis. 72 % of the patients with (no, minor or
non)-obstructive disease had at least one vessel with ob-
structive CAD (Table 1). Also, the vast majority of the study
participants had been referred for angina (96 %), were
under treatment for cardiac arrhythmias and hypertension
(beta blockers, 83 %), were under medication for hyperlip-
idemia (statins, 88 %) and were previous smokers (63 %), all
high risk factors for microvascular dysfunction [29]. It is
important to consider that microvascular dysfunction may
have a major impact on global MBF [6, 29], which may also
have affected myocardial perfusion in vessels with (no,
minor or non)-obstructive CAD. The coincidental effect of
microvascular dysfunction in these patients, could possibly
explain the homogeneous deficiency in coronary blood flow
detected with both quantitative modeling approaches.
Study limitations
The main limitation of this study is the small population
size. However, this is a pilot study to assess the feasibility
of applying the DP model in this cohort of patients with
known or suspected CAD. The above methods need to
be assessed in larger patient cohorts to further assess
their diagnostic accuracy. For perfusion CMR, a single
bolus protocol was implemented to eliminate patient
discomfort, similar to previous quantitative perfusion
CMR studies at 1.5T [11, 19, 20] and at 3T [10]. Thus, it
was impossible to assess any MBF overestimations at the
specific contrast agent dose (0.05 mmol/kg) used in this
study, due to arterial input function saturation issues at
3T. Our group has previously shown that the DP model
was less dependent on saturation effects, although at a
lower contrast agent dose (0.03 mmol/kg) [12]. However,
it is currently shown here that DP modeling achieved
higher sensitivity and specificity in detecting obstructive
CAD in our pilot cohort. This suggests that further in-
vestigation is required to determine whether DP model-
ing may be a more robust method of analysis for single
bolus data at 3T, compared to the Fermi model. Any
possible misregistration between the actual architecture
of vessel territories and the standard 16-segment model
used for myocardial segmentation [14] is a methodo-
logical consideration that should not be excluded in both
visual and quantitative CMR analysis. Both types of ana-
lysis can be subject to overlap of vessel territories which
could in turn affect their sensitivity and/or specificity
[21]. Despite this, the reference method for quantitative
CMR analysis of myocardial perfusion still occurs across
the three major epicardial arteries [14] and this standard
type of analysis was also implemented in this study.
Conclusions
Our analysis demonstrated that diagnostically, the DP
model outperformed the standard Fermi model, in the
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Fig. 4 Mean myocardial blood flow values (SD) at stress in per
vessel (a) and per patient (b) analysis. Mean values and thresholds
for Fermi and distributed parameter modeling are represented with
red diamond, red square dot line and blue triangle, blue dash dot
line, respectively. MBF: myocardial blood flow
Table 5 Results from ROC analysis for all Fermi versus DP
modeling comparisons
Statistics Fermi vs DP modeling (Per
vessel)
Fermi vs DP modeling (Per
patient)
P values from comparisons of ROC curves between models
MBF 0.01* 0.0065*
MPR 0.02* 0.0089*
MPR2 0.21 0.0064*
Difference in AUC of ROC curves between models
MBF -0.08 (-0.15,-0.02) -0.11 (-0.19,-0.03)
MPR -0.10 (-0.18,-0.02) -0.09 (-0.16,-0.02)
MPR2 -0.05 (-0.13, 0.03) -0.07 (-0.12,-0.02)
Statistically significant differences are indicated with *. Comparisons in per
vessel and per patient analysis are presented. Parentheses show 95 %
confidence intervals. DP distributed parameter modeling, MBF myocardial
blood flow, MPR myocardial perfusion reserve, MPR2 myocardial perfusion
reserve of the two lowest scoring segments, AUC area under the curve
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Table 6 Diagnostic performance of Fermi and DP modeling in per vessel and per patient analysis
Haemodynamic parameter-Model Sensitivity Specificity PPV NPV
Fermi-MBF PV 0.85 (0.76 to 0.94) 0.54 (0.43 to 0.65) 0.51 (0.39 to 0.63) 0.86 (0.74 to 0.98)
DP-MBF PV 0.89 (0.79 to 0.99) 0.63 (0.52 to 0.74) 0.58 (0.48 to 0.68) 0.91 (0.84 to 0.98)
Fermi-MPR PV 0.69 (0.50 to 0.88) 0.54 (0.40 to 0.68) 0.46 (0.32 to 0.60) 0.76 (0.62 to 0.90)
DP-MPR PV 0.85 (0.72 to 0.98) 0.61 (0.48 to 0.74) 0.55 (0.43 to 0.67) 0.88 (0.76 to 1.00)
Fermi-MPR2 PV 0.73 (0.58 to 0.88) 0.65 (0.51 to 0.79) 0.54 (0.40 to 0.68) 0.81 (0.68 to 0.94)
DP-MPR2 PV 0.77 (0.62 to 0.92) 0.70 (0.56 to 0.84) 0.58 (0.46 to 0.70) 0.84 (0.75 to 0.94)
Fermi-MBF PP 0.78 (0.66 to 0.90) 0.88 (0.76 to 1.00) 0.93 (0.86 to 1.00) 0.66 (0.55 to 0.77)
DP-MBF PP 0.96 (0.91 to 1.00) 0.92 (0.85 to 0.99) 0.96 (0.91 to 1.00) 0.92 (0.84 to 1.00)
Fermi-MPR PP 0.69 (0.55 to 0.83) 0.83 (0.70 to 0.96) 0.90 (0.80 to 1.00) 0.58 (0.46 to 0.70)
DP-MPR PP 0.88 (0.76 to 1.00) 0.88 (0.78 to 0.98) 0.94 (0.88 to 1.00) 0.78 (0.66 to 0.90)
Fermi-MPR2 PP 0.80 (0.66 to 0.94) 0.79 (0.62 to 0.94) 0.89 (0.78 to 1.00) 0.66 (0.55 to 0.77)
DP-MPR2 PP 0.92 (0.86 to 0.98) 0.83 (0.74 to 0.92) 0.92 (0.86 to 0.98) 0.83 (0.73 to 0.93)
Parentheses show 95 % confidence intervals. PPV positive predictive value, NPV negative predictive value, DP distributed parameter modeling, MBF myocardial
blood flow, MPR myocardial perfusion reserve, MPR2 myocardial perfusion reserve of the two lowest scoring segments, PV per vessel analysis, PP per
patient analysis
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Fig. 5 ROC curves demonstrating diagnostic performance for both models in per patient analysis with (a), (b) and (c) showing measures of
myocardial blood flow at stress, myocardial perfusion reserve and myocardial perfusion reserve of the two lowest scoring segments, respectively
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setting of detecting hypoperfusion corresponding to
haemodynamically significant stenotic vessel territories.
In per patient analysis, the diagnostic performance of
DP modeling-derived MBF at stress outperformed both
Fermi modeling and visual CMR analysis, whilst reach-
ing the highest sensitivity and specificity for obstructive
CAD detection in our pilot population. In the clinical
setting, the haemodynamic threshold for DP-derived
MBF at hyperaemia may have potential to be established
as important biomarker, in order to stratify patients with
at least one vessel with obstructive CAD.
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